ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,329Medicare Part D Prescriptions Filled, Including Refills

Rank: 412 out of 1456

$712K Total Retail Price of All Prescriptions

Rank: 258 out of 1456

319 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 365 234 1 4
OMEPRAZOLE 335 168 2 5
METOCLOPRAMIDE HCL 219 109 3 125
SUCRALFATE 213 122 4 171
LISINOPRIL 197 101 5 3
TRAZODONE HCL 182 101 6 47
CITALOPRAM HBR 168 68 7 22
PREDNISONE 158 68 8 42
SPIRIVA 151 70 9 75
SIMVASTATIN 148 129 10 2
HYDROCODONE-ACETAMINOPHEN 143 42 S3 11 6
OXYCODONE HCL 138 45 S2 12 124
FUROSEMIDE 136 83 13 7
ROPINIROLE HCL 133 93 14 90
CIPROFLOXACIN HCL 130 78 15 58
LOVASTATIN 130 82 15 40
HYDROCHLOROTHIAZIDE 128 86 17 10
AMLODIPINE BESYLATE 127 85 18 1
METFORMIN HCL 127 63 18 8
MIRTAZAPINE 119 80 20 65
CARISOPRODOL 119 0 R 20 80
METOPROLOL TARTRATE 104 65 22 12
CARVEDILOL 93 83 23 20
CRESTOR 89 44 24 26
AZITHROMYCIN 87 34 25 44
GABAPENTIN 85 42 26 13
TRAMADOL HCL 83 64 27 17
SPIRONOLACTONE 83 74 27 73
BUPROPION XL 75 28 29 165
PANTOPRAZOLE SODIUM 75 46 29 43
WARFARIN SODIUM 74 48 31 21
NAPROXEN 72 49 32 100
POTASSIUM CHLORIDE 72 40 32 15
AMOX TR-POTASSIUM CLAVULANATE 72 39 32 118
DOXYCYCLINE HYCLATE 69 28 35 129
FLUOXETINE HCL 68 36 36 55
CLOPIDOGREL 67 52 37 32
NAMENDA 63 63 38 38
NEXIUM 62 11 39 23
SINGULAIR 61 24 40 83
PROMETHAZINE HCL 60 0 R 41 77
DEXILANT 60 29 41 169
AMOXICILLIN 56 27 43 112
FLUCONAZOLE 56 30 43 148
ADVAIR DISKUS 55 21 45 63
LYRICA 55 38 45 91
FLUTICASONE PROPIONATE 55 42 45 28
DONEPEZIL HCL 54 53 48 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 33 49 24
MONTELUKAST SODIUM 52 25 50 135
LACTULOSE 51 37 51 192
PROAIR HFA 51 14 51 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.